scholarly article | Q13442814 |
P356 | DOI | 10.1161/CIRCRESAHA.110.226456 |
P698 | PubMed publication ID | 21030722 |
P50 | author | Christian Weber | Q37838769 |
P2093 | author name string | Sebastian F Mause | |
P433 | issue | 9 | |
P921 | main subject | communication network | Q13425103 |
P304 | page(s) | 1047-1057 | |
P577 | publication date | 2010-10-01 | |
P1433 | published in | Circulation Research | Q2599020 |
P1476 | title | Microparticles: protagonists of a novel communication network for intercellular information exchange | |
P478 | volume | 107 |
Q33799866 | A Refined Bead-Free Method to Identify Astrocytic Exosomes in Primary Glial Cultures and Blood Plasma |
Q47910486 | A comparative evaluation of two decompression procedures for technical diving using inflammatory responses: compartmental versus ratio deco. |
Q46306454 | A historical and evolutionary perspective on the biological significance of circulating DNA and extracellular vesicles |
Q38321079 | A novel method for overexpression of peroxisome proliferator‐activated receptor‐γ in megakaryocyte and platelet microparticles achieves transcellular signaling |
Q30370837 | Acid sphingomyelinase is activated in sickle cell erythrocytes and contributes to inflammatory microparticle generation in SCD. |
Q60175879 | Activating the Nucleic Acid-Sensing Machinery for Anticancer Immunity |
Q55420253 | Alk5/Runx1 signaling mediated by extracellular vesicles promotes vascular repair in acute respiratory distress syndrome. |
Q38644253 | An overview of the role of microparticles/microvesicles in blood components: Are they clinically beneficial or harmful? |
Q36814937 | Analyses of Endothelial Cells and Endothelial Progenitor Cells Released Microvesicles by Using Microbead and Q-dot Based Nanoparticle Tracking Analysis. |
Q33597012 | Anti-proliferative and anti-tumour effects of lymphocyte-derived microparticles are neither species- nor tumour-type specific |
Q26771759 | Antibody-Based Assays for Phenotyping of Extracellular Vesicles |
Q42175264 | Apoptotic cell-derived ICAM-3 promotes both macrophage chemoattraction to and tethering of apoptotic cells. |
Q26852271 | Applications of targeted proteomics in systems biology and translational medicine |
Q30430798 | Assessment of endothelial dysfunction in childhood obesity and clinical use. |
Q38104276 | Association of microparticles and preeclampsia |
Q36543708 | Astrocytes as secretory cells of the central nervous system: idiosyncrasies of vesicular secretion |
Q35633008 | Avoiding false positive antigen detection by flow cytometry on blood cell derived microparticles: the importance of an appropriate negative control |
Q47990314 | Balance Between the Proinflammatory and Anti-Inflammatory Immune Responses with Blood Transfusion in Sepsis. |
Q47227156 | Bifacial effects of engineering tumour cell-derived exosomes on human natural killer cells |
Q41422353 | Biogenesis of Pro-senescent Microparticles by Endothelial Colony Forming Cells from Premature Neonates is driven by SIRT1-Dependent Epigenetic Regulation of MKK6. |
Q41006936 | Biological markers of prognosis, response to therapy and outcome in ovarian carcinoma. |
Q33394857 | Blood platelets and inflammation: Their relationship with liver and digestive diseases |
Q40251118 | Blood transfusion and inflammation |
Q26830366 | Breaking the mold: transcription factors in the anucleate platelet and platelet-derived microparticles |
Q44741513 | Bubbles, microparticles, and neutrophil activation: changes with exercise level and breathing gas during open-water SCUBA diving |
Q51100129 | C1-Inhibitor Decreases the Release of Vasculitis-Like Chemotactic Endothelial Microvesicles |
Q33415885 | Ca2+ switches the effect of PS-containing membranes on Factor Xa from activating to inhibiting: implications for initiation of blood coagulation |
Q26752073 | Can microfluidics address biomanufacturing challenges in drug/gene/cell therapies? |
Q47678443 | Caspase-11-mediated endothelial pyroptosis underlies endotoxemia-induced lung injury |
Q37524901 | Cell biology of ischemia/reperfusion injury |
Q37295504 | Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation? |
Q38034393 | Cell-derived microparticles in stored blood products: innocent-bystanders or effective mediators of post-transfusion reactions? |
Q36551157 | Cellular connections, microenvironment and brain angiogenesis in diabetes: Lost communication signals in the post-stroke period |
Q64882233 | Changes of Circulating Extracellular Vesicles from the Liver after Roux-en-Y Bariatric Surgery. |
Q51767823 | Characterization of microparticles in patients with venous malformations of the head and neck |
Q40242576 | Chemotherapy-induced intestinal inflammatory responses are mediated by exosome secretion of double-strand DNA via AIM2 inflammasome activation. |
Q38729517 | Childhood obesity-related endothelial dysfunction: an update on pathophysiological mechanisms and diagnostic advancements |
Q46329191 | Chronic Obstructive Pulmonary Disease: A Disease of the Endothelium? |
Q26749422 | Circulating Endothelial Microparticles: A Key Hallmark of Atherosclerosis Progression |
Q58714196 | Circulating H3Cit is elevated in a human model of endotoxemia and can be detected bound to microvesicles |
Q51644749 | Circulating Microparticles Decrease After Cardiac Stress in Patients With Significant Coronary Artery Stenosis. |
Q89537829 | Circulating Tissue Factor-Positive Procoagulant Microparticles in Patients with Type 1 Diabetes |
Q35086811 | Circulating endothelial progenitor cells and cellular membrane microparticles in db/db diabetic mouse: possible implications in cerebral ischemic damage |
Q50055443 | Circulating exosomal microRNAs reveal the mechanism of Fructus Meliae Toosendan-induced liver injury in mice. |
Q38095110 | Circulating miRNAs: Novel Biomarkers of Acute Coronary Syndrome? |
Q38045189 | Circulating miRNAs: Reflecting or Affecting Cardiovascular Disease? |
Q34374389 | Circulating microRNAs as a fingerprint for endometrial endometrioid adenocarcinoma |
Q38274805 | Circulating microRNAs in cardiovascular diseases: from biomarkers to therapeutic targets |
Q34032112 | Circulating microRNAs, novel biomarkers of acute myocardial infarction: a systemic review |
Q46647964 | Circulating microparticles and plasma levels of soluble E- and P-selectins in patients with systemic sclerosis |
Q35014306 | Circulating microparticles carry oxidation-specific epitopes and are recognized by natural IgM antibodies |
Q31137300 | Circulating microparticles from Crohn's disease patients cause endothelial and vascular dysfunctions |
Q87414676 | Circulating microparticles in severe preeclampsia |
Q34680832 | Circulating microparticles: square the circle |
Q37435694 | Clinical marker of platelet hyperreactivity in diabetes mellitus |
Q26747154 | Clinical relevance of circulating cell-free microRNAs in ovarian cancer |
Q33425421 | Complement Interactions with Blood Cells, Endothelial Cells and Microvesicles in Thrombotic and Inflammatory Conditions |
Q33720618 | Deciphering the role of ectosomes in cancer development and progression: focus on the proteome. |
Q39224333 | Delivery of chemotherapeutic drugs in tumour cell-derived microparticles. |
Q35265265 | Detection of microparticles from human red blood cells by multiparametric flow cytometry. |
Q53008414 | Detection of microparticles of leukocytic origin in the peripheral blood in normal pregnancy and preeclampsia. |
Q55239743 | Dexamethasone-Activated MSCs Release MVs for Stimulating Osteogenic Response. |
Q26771125 | Diagnostic and prognostic value of circulating microRNAs in heart failure with preserved and reduced ejection fraction |
Q41095069 | Differentiating sepsis from non-infectious systemic inflammation based on microvesicle-bacteria aggregation |
Q37981459 | Do microRNAs regulate bone marrow stem cell niche physiology? |
Q37732309 | Do platelet-derived microparticles play a role in depression, inflammation, and acute coronary syndrome? |
Q90587527 | Downregulation of Microparticle Release and Pro-Inflammatory Properties of Activated Human Polymorphonuclear Neutrophils by LMW Fucoidan |
Q47328598 | Dynamics of circulating microparticles in obesity after weight loss. |
Q51693347 | Effect of endothelin-1 and endothelin receptor blockade on the release of microparticles |
Q34763957 | Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity |
Q42174913 | Effects of Chronic Exercise on Endothelial Progenitor Cells and Microparticles in Professional Runners |
Q93133348 | Effects of Cryopreservation on Microparticles Concentration, Procoagulant Function, Size Distribution, and Morphology |
Q92618586 | Effects of Microvesicles on Cell Apoptosis under Hypoxia |
Q37316289 | Effects of endothelial progenitor cell-derived microvesicles on hypoxia/reoxygenation-induced endothelial dysfunction and apoptosis |
Q89909424 | Effects of hypoxic-ischemic pre-treatment on microvesicles derived from endothelial progenitor cells |
Q50875200 | Elevated circulating levels of tissue factor-positive microvesicles are associated with distant metastasis in lung cancer |
Q36275429 | Elevated levels of endothelial-derived microparticles, and serum CXCL9 and SCGF-β are associated with unstable asymptomatic carotid plaques. |
Q38138876 | Emerging paradigms in arterial thrombosis |
Q35522530 | Endocytic deficiency induced by ITSN-1s knockdown alters the Smad2/3-Erk1/2 signaling balance downstream of Alk5 |
Q84266986 | Endosis and Exosis: New Names for Fusion and Budding |
Q36970177 | Endothelial Microparticle-Derived Reactive Oxygen Species: Role in Endothelial Signaling and Vascular Function |
Q35634914 | Endothelial cells suppress monocyte activation through secretion of extracellular vesicles containing antiinflammatory microRNAs |
Q43513332 | Endothelial injury in sepsis |
Q33618681 | Endothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation |
Q38688884 | Endothelial microparticles prevent lipid-induced endothelial damage via Akt/eNOS signaling and reduced oxidative stress. |
Q36057489 | Endothelial microparticles reduce ICAM-1 expression in a microRNA-222-dependent mechanism |
Q38001993 | Endothelial microparticles: missing link in endothelial dysfunction? |
Q90652758 | Endothelial- and Immune Cell-Derived Extracellular Vesicles in the Regulation of Cardiovascular Health and Disease |
Q36476019 | Endothelium-derived microparticles from chronically thromboembolic pulmonary hypertensive patients facilitate endothelial angiogenesis |
Q41771482 | Evidence for Transfer of Membranes from Mesenchymal Stem Cells to HL-1 Cardiac Cells |
Q41377815 | Evidence for a Hypercoagulable State in Women With Ovarian Endometriomas |
Q27022210 | Evolving Role of Microparticles in the Pathophysiology of Endothelial Dysfunction |
Q38667736 | Exosomal miRNAs in Heart Disease |
Q40886790 | Exosomal microRNA miR-92a concentration in serum reflects human brown fat activity |
Q92059907 | Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer |
Q34034189 | Exosomes and the kidney: blaming the messenger. |
Q34064539 | Exosomes from Plasmodium yoelii-infected reticulocytes protect mice from lethal infections. |
Q28066481 | Exploring circulating micro-RNA in the neoadjuvant treatment of breast cancer |
Q37472712 | Exploring experimental cerebral malaria pathogenesis through the characterisation of host-derived plasma microparticle protein content |
Q94465774 | Extracellular Endothelial Cell-Derived Vesicles: Emerging Role in Cardiac and Vascular Remodeling in Heart Failure |
Q61807604 | Extracellular Vesicles in Liver Diseases: Meeting Report from the International Liver Congress 2018 |
Q27022494 | Extracellular Vesicles in Multiple Sclerosis: What are They Telling Us? |
Q38842995 | Extracellular Vesicles: Satellites of Information Transfer in Cancer and Stem Cell Biology |
Q91307378 | Extracellular blebs: Artificially-induced extracellular vesicles for facile production and clinical translation |
Q35561452 | Extracellular movement of signaling molecules. |
Q48001492 | Extracellular vesicle-mediated bone metabolism in the bone microenvironment |
Q57081259 | Extracellular vesicles generated by placental tissues ex vivo: A transport system for immune mediators and growth factors |
Q55097241 | Extracellular vesicles in mesenchymal stromal cells: A novel therapeutic strategy for stroke. |
Q37632337 | Extracellular vesicles in prostate cancer: new future clinical strategies? |
Q39453434 | Extracellular vesicles in renal disease |
Q48195802 | Extracellular vesicles mediate intercellular communication: Transfer of functionally active microRNAs by microvesicles into phagocytes. |
Q37996375 | Extracellular vesicles--vehicles that spread cancer genes |
Q36803149 | Extracellular vesicles: communication, coercion, and conditioning |
Q34736260 | Fas-induced apoptosis increases hepatocyte tissue factor procoagulant activity in vitro and in vivo. |
Q92446437 | Fourier Transform Infrared Spectroscopy as a Cancer Screening and Diagnostic Tool: A Review and Prospects |
Q38145557 | Gateway to understanding microparticles: standardized isolation and identification of plasma membrane-derived vesicles |
Q38903280 | Generation of lymphocytic microparticles and detection of their proapoptotic effect on airway epithelial cells. |
Q38793495 | Glomerular cell crosstalk. |
Q48523521 | Hematopoietic stem cell-derived exosomes promote hematopoietic differentiation of mouse embryonic stem cells in vitro via inhibiting the miR126/Notch1 pathway |
Q35402769 | Hemolysis-free plasma miR-214 as novel biomarker of gastric cancer and is correlated with distant metastasis |
Q36894126 | Hepatic Stellate Cell-Derived Microvesicles Prevent Hepatocytes from Injury Induced by APAP/H2O2. |
Q50437551 | High correlation between 2 flow cytometry platforms in the microparticles analysis using a new calibrated beads strategy. |
Q45027017 | High glucose condition increases NADPH oxidase activity in endothelial microparticles that promote vascular inflammation. |
Q50350632 | How do megakaryocytic microparticles target and deliver cargo to alter the fate of hematopoietic stem cells? |
Q36882814 | Human cardiospheres as a source of multipotent stem and progenitor cells |
Q35879526 | Identification of miR-93 as a suitable miR for normalizing miRNA in plasma of tuberculosis patients. |
Q57559233 | Imaging and Therapeutic Potential of Extracellular Vesicles |
Q53822322 | Imbalance between endothelial damage and repair capacity in chronic obstructive pulmonary disease. |
Q37229687 | Immunomodulatory role of microRNAs transferred by extracellular vesicles. |
Q37316399 | Impact of endothelial microparticles on coagulation, inflammation, and angiogenesis in age-related vascular diseases |
Q56767635 | Impaired immune phenotype of circulating endothelial-derived microparticles in patients with metabolic syndrome and diabetes mellitus |
Q38829920 | Impaired vascular function contributes to exercise intolerance in chronic kidney disease |
Q36507134 | Increased plasma levels of microparticles expressing CD39 and CD133 in acute liver injury. |
Q47343207 | Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis |
Q37986175 | Inflammation in atherosclerosis: a cause or a result of vascular disorders? |
Q51007446 | Inflammatory responses to acute elevations of carbon dioxide in mice |
Q40061733 | Influence of Diabetes on Circulating Apoptotic Microparticles in Patients with Chronic Hepatitis C. |
Q38689619 | Influence of red blood cell-derived microparticles upon vasoregulation |
Q52571055 | Initiation and Propagation of Vascular Calcification Is Regulated by a Concert of Platelet- and Smooth Muscle Cell-Derived Extracellular Vesicles |
Q39108482 | Innate Immune Cell–Derived Microparticles Facilitate Hepatocarcinoma Metastasis by Transferring Integrin αMβ2 to Tumor Cells |
Q89846118 | Inside(sight) of tiny communicator: exosome biogenesis, secretion, and uptake |
Q54941249 | Interaction of Platelet-Derived Microparticles with a Human B-Lymphoblast Cell Line: A Clue for the Immunologic Function of the Microparticles. |
Q51159605 | Intercellular transfer of miR-126-3p by endothelial microparticles reduces vascular smooth muscle cell proliferation and limits neointima formation by inhibiting LRP6. |
Q27004360 | Intercellular transport of microRNAs |
Q58230148 | Intracoronary microparticles and microvascular obstruction in patients with ST elevation myocardial infarction undergoing primary percutaneous intervention |
Q85778286 | Intramicroparticle nitrogen dioxide is a bubble nucleation site leading to decompression-induced neutrophil activation and vascular injury |
Q89719755 | Intravenous Administration of Allogenic Cell-Derived Microvesicles of Healthy Origins Defend Against Atherosclerotic Cardiovascular Disease Development by a Direct Action on Endothelial Progenitor Cells |
Q26852338 | Is the neutrophil a 'prima donna' in the procoagulant process during sepsis? |
Q38072506 | Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges |
Q39109413 | Ischemia/Reperfusion |
Q40571835 | Isolation and characterization of vesicular and non-vesicular microRNAs circulating in sera of partially hepatectomized rats |
Q28087005 | Isolation of extracellular vesicles: Determining the correct approach (Review) |
Q26853101 | L-type calcium channel targeting and local signalling in cardiac myocytes |
Q36809835 | Leukemia Stem Cell-Released Microvesicles Promote the Survival and Migration of Myeloid Leukemia Cells and These Effects Can Be Inhibited by MicroRNA34a Overexpression |
Q41292245 | Levels of activated platelet-derived microvesicles in patients with soft tissue sarcoma correlate with an increased risk of venous thromboembolism |
Q37993698 | Lipid-based carriers of microRNAs and intercellular communication |
Q58840414 | Lungs, Bone Marrow, and Adipose Tissue. A Network Approach to the Pathobiology of Chronic Obstructive Pulmonary Disease |
Q39000615 | Lymphocyte-derived microparticles induce apoptosis of airway epithelial cells through activation of p38 MAPK and production of arachidonic acid. |
Q38626237 | MRP1 and its role in anticancer drug resistance |
Q37393027 | Making sense in antisense: therapeutic potential of noncoding RNAs in diabetes-induced vascular dysfunction. |
Q47571970 | Marathon running increases circulating endothelial- and thrombocyte-derived microparticles |
Q38569109 | Membrane microparticles: shedding new light into cancer cell communication. |
Q97423950 | Methotrexate-loaded tumour-cell-derived microvesicles can relieve biliary obstruction in patients with extrahepatic cholangiocarcinoma |
Q35114995 | MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease |
Q46308935 | MicroRNA-141 is upregulated in preeclamptic placentae and regulates trophoblast invasion and intercellular communication. |
Q49695387 | MicroRNA-145-5p and microRNA-320a encapsulated in endothelial microparticles contribute to the progression of vasculitis in acute Kawasaki Disease |
Q38115105 | MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease. |
Q38110225 | MicroRNAs as Biomarkers for Ischemic Heart Disease |
Q42121996 | MicroRNAs in Vascular Biology |
Q38005243 | MicroRNAs in adipose tissue: their role in adipogenesis and obesity |
Q38051994 | MicroRNAs: Important Modulators of oxLDL-Mediated Signaling in Atherosclerosis |
Q57168499 | Microfluidics-based on-a-chip systems for isolating and analysing extracellular vesicles |
Q33693525 | Microparticle Formation in Peritoneal Dialysis: A Proof of Concept Study. |
Q34253188 | Microparticle content of plasma for transfusion is influenced by the whole blood hold conditions: pre-analytical considerations for proteomic investigations |
Q35927423 | Microparticle-Induced Activation of the Vascular Endothelium Requires Caveolin-1/Caveolae |
Q34533653 | Microparticle-mediated transfer of the viral receptors CAR and CD46, and the CFTR channel in a CHO cell model confers new functions to target cells |
Q84210387 | Microparticles and Paracrine Signaling in Portal Hypertension: Crucial Conversations or Idle Chat? |
Q38021265 | Microparticles and acute lung injury |
Q46328110 | Microparticles are new biomarkers of septic shock-induced disseminated intravascular coagulopathy |
Q92479208 | Microparticles as Potential Mediators of High Glucose-Induced Renal Cell Injury |
Q35928145 | Microparticles as immune regulators in infectious disease - an opinion |
Q27016054 | Microparticles as mediators and biomarkers of rheumatic disease |
Q50222463 | Microparticles from splenectomized β-thalassemia/HbE patients play roles on procoagulant activities with thrombotic potential |
Q33666562 | Microparticles from stored red blood cells activate neutrophils and cause lung injury after hemorrhage and resuscitation. |
Q35131040 | Microparticles in hemostasis and thrombosis. |
Q34667556 | Microparticles in multiple sclerosis and clinically isolated syndrome: effect on endothelial barrier function |
Q48102982 | Microparticles produced by human papillomavirus type 16 E7-expressing cells impair antigen presenting cell function and the cytotoxic T cell response. |
Q35306479 | Microparticles release by adipocytes act as "find-me" signals to promote macrophage migration |
Q37032283 | Microparticles variability in fresh frozen plasma: preparation protocol and storage time effects. |
Q38012180 | Microparticles, not only markers but also a therapeutic target in the early stage of diabetic retinopathy and vascular aging |
Q37922118 | Microparticles: a critical component in the nexus between inflammation, immunity, and thrombosis |
Q35792749 | Microparticles: major transport vehicles for distinct microRNAs in circulation |
Q38242740 | Microparticles: new light shed on the understanding of venous thromboembolism. |
Q47127903 | Microvesicle Involvement in Shiga Toxin-Associated Infection |
Q37580782 | Microvesicles Derived from Inflammation-Challenged Endothelial Cells Modulate Vascular Smooth Muscle Cell Functions |
Q49807920 | Microvesicles as Emerging Biomarkers and Therapeutic Targets in Cardiometabolic Diseases |
Q26768704 | Microvesicles as a potential biomarker of neoplastic diseases and their role in development and progression of neoplasm |
Q37841221 | Microvesicles as mediators of intercellular communication in cancer—the emerging science of cellular ‘debris’ |
Q36635032 | Microvesicles as potential ovarian cancer biomarkers |
Q54520697 | Microvesicles derived from endothelial progenitor cells enhance neoangiogenesis of human pancreatic islets. |
Q33746472 | Microvesicles derived from human Wharton's Jelly mesenchymal stromal cells ameliorate renal ischemia-reperfusion injury in rats by suppressing CX3CL1. |
Q57574568 | Microvesicles from platelets: novel drivers of vascular inflammation |
Q37273154 | Microvesicles: potential markers and mediators of endothelial dysfunction |
Q27013859 | Milk fat globule epidermal growth factor VIII signaling in arterial wall remodeling |
Q64257965 | Mitochondrial Dysfunction and Aging: Insights from the Analysis of Extracellular Vesicles |
Q40659069 | Monocyte exosomes induce adhesion molecules and cytokines via activation of NF-κB in endothelial cells |
Q35182740 | Monocytic microparticles activate endothelial cells in an IL-1β–dependent manner |
Q36840791 | Multilayer Membranes of Glycosaminoglycans and Collagen I Biomaterials Modulate the Function and Microvesicle Release of Endothelial Progenitor Cells |
Q36531479 | N-Acetylcysteine Amide Protects Against Oxidative Stress-Induced Microparticle Release From Human Retinal Pigment Epithelial Cells |
Q27300845 | Nano-zymography Using Laser-Scanning Confocal Microscopy Unmasks Proteolytic Activity of Cell-Derived Microparticles |
Q90009893 | Neural maturation enhanced by exercise-induced extracellular derivatives |
Q64102043 | Neural stem cell-derived small extracellular vesicles attenuate apoptosis and neuroinflammation after traumatic spinal cord injury by activating autophagy |
Q34425335 | Neurokinin 1 receptor mediates membrane blebbing and sheer stress-induced microparticle formation in HEK293 cells |
Q55652396 | New players in haemostasis and thrombosis. |
Q51493562 | Non-contact acoustic capture of microparticles from small plasma volumes |
Q39201920 | Nonclinical safety biomarkers of drug-induced vascular injury: current status and blueprint for the future |
Q26778352 | Novel insights into the regulation of cyclooxygenase-2 expression by platelet-cancer cell cross-talk |
Q28088373 | Novel methodologies for biomarker discovery in atherosclerosis |
Q53063504 | Oat-enriched diet reduces inflammatory status assessed by circulating cell-derived microparticle concentrations in type 2 diabetes |
Q41974700 | Obesity reduces the pro-angiogenic potential of adipose tissue stem cell-derived extracellular vesicles (EVs) by impairing miR-126 content: impact on clinical applications. |
Q36193774 | Oncogenic extracellular vesicles in brain tumor progression |
Q45876736 | Origin and levels of circulating microparticles in normal pregnancy: A longitudinal observation in healthy women. |
Q36674531 | Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation |
Q47787820 | Oxidized low-density lipoprotein-induced microparticles promote endothelial monocyte adhesion via intercellular adhesion molecule 1. |
Q35207653 | Pathologic mechanical stress and endotoxin exposure increases lung endothelial microparticle shedding |
Q36324332 | Pattern of circulating microparticles in chronic heart failure patients with metabolic syndrome: Relevance to neurohumoral and inflammatory activation |
Q37267758 | Personalized cytomic assessment of vascular health: Evaluation of the vascular health profile in diabetes mellitus |
Q37259379 | Phosphatidylethanolamine is externalized at the surface of microparticles. |
Q36728170 | Phosphatidylserine exposing-platelets and microparticles promote procoagulant activity in colon cancer patients |
Q49495752 | Physiologic Impact of Circulating RBC Microparticles upon Blood-Vascular Interactions |
Q35949057 | Plasma BIN1 correlates with heart failure and predicts arrhythmia in patients with arrhythmogenic right ventricular cardiomyopathy |
Q36922192 | Plasma Levels of Endothelial Microparticles Bearing Monomeric C-reactive Protein are Increased in Peripheral Artery Disease |
Q37827208 | Plasma membrane repair and cellular damage control: The annexin survival kit |
Q30528297 | Plasma membrane-derived microvesicles released from tip endothelial cells during vascular sprouting |
Q38581119 | Platelet MicroRNAs: An Overview |
Q26823775 | Platelet function tests: a review of progresses in clinical application |
Q46366691 | Platelet microparticles infiltrating solid tumors transfer miRNAs that suppress tumor growth |
Q85574310 | Platelet microparticles: reinforcing the hegemony of platelets in atherothrombosis |
Q47106708 | Platelet-Derived Microvesicles in Cardiovascular Diseases. |
Q38717559 | Platelet-derived microparticles and soluble factors differentially regulate human endometrial epithelial cell movement |
Q57183566 | Platelet-derived microparticles are implicated in remote ischemia conditioning in a rat model of cerebral infarction |
Q51829369 | Platelet-derived microparticles augment the adhesion and neovascularization capacities of circulating angiogenic cells obtained from atherosclerotic patients |
Q100427953 | Platelet-derived microparticles enhance megakaryocyte differentiation and platelet generation via miR-1915-3p |
Q86700895 | Platelets and neurovascular inflammation |
Q36058568 | Platelets and platelet-like particles mediate intercellular RNA transfer |
Q38729940 | Platelets are a possible regulator of human endometrial re-epithelialization during menstruation. |
Q39294808 | Platelets as crucial partners for tumor metastasis: from mechanistic aspects to pharmacological targeting |
Q28085020 | Platelets in inflammation and atherogenesis |
Q39408199 | Platelets, circulating tumor cells, and the circulome. |
Q38038134 | Platelets: key players in vascular inflammation |
Q39248498 | Platelets: much more than bricks in a breached wall. |
Q49805134 | Podocyte-derived microparticles promote proximal tubule fibrotic signaling via p38 MAPK and CD36. |
Q54938261 | Potential biological functions of microvesicles derived from adenoid cystic carcinoma. |
Q37742360 | Pre-incubation with hucMSC-exosomes prevents cisplatin-induced nephrotoxicity by activating autophagy |
Q50660827 | Pro-angiogenic capacities of microvesicles produced by skin wound myofibroblasts |
Q41499739 | Proportions of several types of plasma and urine microparticles are increased in patients with rheumatoid arthritis with active disease |
Q38787457 | Proteinase 3 Is a Phosphatidylserine-binding Protein That Affects the Production and Function of Microvesicles |
Q90281621 | Proteomic Analysis of Urinary Microvesicles and Exosomes in Medullary Sponge Kidney Disease and Autosomal Dominant Polycystic Kidney Disease |
Q45806022 | Proteomic analysis of TNF-α-activated endothelial cells and endothelial microparticles |
Q38106664 | Proteomics of plaques and novel sources of potential biomarkers for atherosclerosis |
Q38080806 | Proteomics, transcriptomics and lipidomics of exosomes and ectosomes. |
Q50498904 | Purification Protocols for Extracellular Vesicles. |
Q38375370 | Quantitative proteome analysis of plasma microparticles for the characterization of HCV-induced hepatic cirrhosis and hepatocellular carcinoma. |
Q33581791 | Recent Progress in Research on the Pathogenesis of Pulmonary Thromboembolism: An Old Story with New Perspectives |
Q36854004 | Recent progress on lipid lateral heterogeneity in plasma membranes: From rafts to submicrometric domains |
Q35034340 | Regulation of cancer metastasis by cell-free miRNAs |
Q93377009 | Regulation of capillary tubules and lipid formation in vascular endothelial cells and macrophages via extracellular vesicle-mediated microRNA-4306 transfer |
Q35542818 | Release of Intracoronary Microparticles during Stent Implantation into Stable Atherosclerotic Lesions under Protection with an Aspiration Device |
Q50933740 | Remote Ischemic Preconditioning-Mediated Neuroprotection against Stroke is Associated with Significant Alterations in Peripheral Immune Responses |
Q36979231 | Reversing drug resistance of soft tumor-repopulating cells by tumor cell-derived chemotherapeutic microparticles |
Q38117725 | Revisited role of microparticles in arterial and venous thrombosis. |
Q26777595 | Role and Function of MicroRNAs in Extracellular Vesicles in Cardiovascular Biology |
Q53112227 | Role of erythrocytes and platelets in the hypercoagulable status in polycythemia vera through phosphatidylserine exposure and microparticle generation |
Q38151957 | Role of platelets in inflammation and cancer: novel therapeutic strategies |
Q39396080 | Role of receptor-mediated endocytosis in the antiangiogenic effects of human T lymphoblastic cell-derived microparticles |
Q38034092 | Role of tissue factor in atherothrombosis |
Q64902212 | Roles of Specialized Pro-Resolving Lipid Mediators in Cerebral Ischemia Reperfusion Injury. |
Q83721123 | Science to Practice: Imaging of Cellular Microparticles—Magic Dust or Just Dirt? |
Q92239589 | Self-DNA at the Epicenter of SLE: Immunogenic Forms, Regulation, and Effects |
Q37141019 | Serum extracellular vesicle protein levels are associated with acute coronary syndrome |
Q64102450 | Short-Term Low-Carbohydrate High-Fat Diet in Healthy Young Males Renders the Endothelium Susceptible to Hyperglycemia-Induced Damage, An Exploratory Analysis |
Q84589325 | Small RNA Biomarkers Come of Age |
Q38834645 | Smart blood cell and microvesicle-based Trojan horse drug delivery: Merging expertise in blood transfusion and biomedical engineering in the field of nanomedicine |
Q41851773 | Stability of membranous nanostructures: a possible key mechanism in cancer progression |
Q38798555 | Stem Cell Extracellular Vesicles: Extended Messages of Regeneration |
Q34374075 | Storage-Induced Changes in Erythrocyte Membrane Proteins Promote Recognition by Autoantibodies |
Q27317115 | Structural and functional characterization of endothelial microparticles released by cigarette smoke. |
Q82591348 | Studies of Circulating Microparticle Release in Peripheral Blood After Pancreatic Islet Transplantation |
Q35733635 | Sulfur vesicles from Thermococcales: A possible role in sulfur detoxifying mechanisms. |
Q35586695 | Super-resolved calibration-free flow cytometric characterization of platelets and cell-derived microparticles in platelet-rich plasma |
Q41923180 | T lymphocytes export proteasomes by way of microparticles: a possible mechanism for generation of extracellular proteasomes |
Q36194838 | TLR4 signaling induces the release of microparticles by tumor cells that regulate inflammatory cytokine IL-6 of macrophages via microRNA let-7b |
Q35460716 | Techniques for the analysis of extracellular vesicles using flow cytometry |
Q36215909 | The Association of Subclinical Hypothyroidism and Pattern of Circulating Endothelial-Derived Microparticles Among Chronic Heart Failure Patients. |
Q47112260 | The Emerging Roles of Microparticles in Diabetic Nephropathy |
Q36119260 | The Role of Circulating Platelets Microparticles and Platelet Parameters in Acute Ischemic Stroke Patients |
Q90224429 | The Role of Exo-miRNAs in Cancer: A Focus on Therapeutic and Diagnostic Applications |
Q38106745 | The Role of Microparticles in the Pathogenesis of Rheumatoid Arthritis and Systemic Lupus Erythematosus |
Q41068275 | The Role of Microvesicles Derived from Mesenchymal Stem Cells in Lung Diseases |
Q42713176 | The Spectrum of Circulating RNA: A Window into Systems Toxicology |
Q58998678 | The Systems Biology of Stem Cell Released Molecules—Based Therapeutics |
Q35122712 | The anti-oxidative role of micro-vesicles derived from human Wharton-Jelly mesenchymal stromal cells through NOX2/gp91(phox) suppression in alleviating renal ischemia-reperfusion injury in rats |
Q85399419 | The curious case of miRNAs in circulation: potential diagnostic biomarkers? |
Q36975014 | The effects of microvesicles on endothelial progenitor cells are compromised in type 2 diabetic patients via downregulation of the miR-126/VEGFR2 pathway |
Q38184831 | The emerging roles of microvesicles in liver diseases |
Q37047827 | The origin and properties of extracellular DNA: from PAMP to DAMP. |
Q36647084 | The origin of circulating CD36 in type 2 diabetes. |
Q42152321 | The predictive role of circulating microparticles in patients with chronic heart failure. |
Q35171280 | The role of galectin-3 and galectin-3-binding protein in venous thrombosis |
Q38638694 | The role of microparticles in inflammation and transfusion: A concise review |
Q90430751 | The role of microvesicles containing microRNAs in vascular endothelial dysfunction |
Q57170189 | The role of neutrophils in thrombosis |
Q52086673 | The signature of circulating microparticles in heart failure patients with metabolic syndrome |
Q41631738 | The transition of smooth muscle cells from a contractile to a migratory, phagocytic phenotype: direct demonstration of phenotypic modulation |
Q33412254 | Therapeutic drug-induced platelet apoptosis: an overlooked issue in pharmacotoxicology |
Q38031213 | Therapeutic potential of mesenchymal stem cell-derived microvesicles. |
Q38102904 | Thrombus Aspiration Therapy and Coronary Thrombus Components in Patients with Acute ST-Elevation Myocardial Infarction |
Q35568437 | Transcellular delivery of vesicular SOCS proteins from macrophages to epithelial cells blunts inflammatory signaling |
Q46439891 | Transcriptomic profiling of platelet senescence and platelet extracellular vesicles. |
Q38938854 | Transformation of cell-derived microparticles into quantum-dot-labeled nanovectors for antitumor siRNA delivery |
Q37406648 | Transglutaminse 2 and EGGL, the Protein Cross-Link Formed by Transglutaminse 2, As Therapeutic Targets for Disabilities of Old Age |
Q36670960 | Trial protocol for a randomised controlled trial of red cell washing for the attenuation of transfusion-associated organ injury in cardiac surgery: the REDWASH trial |
Q35646453 | Tumor Interstitial Fluid Formation, Characterization, and Clinical Implications |
Q36821072 | Tumor cell-derived microparticles polarize M2 tumor-associated macrophages for tumor progression |
Q36060221 | Tumor cell-derived microparticles: a new form of cancer vaccine |
Q99720308 | Tumor-derived microparticles in tumor immunology and immunotherapy |
Q39042430 | Tumor-derived microparticles induce bone marrow-derived cell mobilization and tumor homing: a process regulated by osteopontin |
Q27023509 | Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers |
Q37169096 | Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients |
Q39047723 | UVB-generated Microvesicle Particles: A Novel Pathway by Which a Skin-specific Stimulus Could Exert Systemic Effects. |
Q35123704 | Ultrastructural analysis of healthy synovial fluids in three mammalian species. |
Q36438947 | Ultrastructural evidence of exosome secretion by progenitor cells in adult mouse myocardium and adult human cardiospheres |
Q38907024 | Update on extracellular vesicles inside red blood cell storage units: Adjust the sails closer to the new wind |
Q39413009 | Update on the role of endothelial cells in trauma |
Q36905637 | VE-cadherin cleavage by ovarian cancer microparticles induces β-catenin phosphorylation in endothelial cells |
Q40324178 | Vascular Health Profile predicts cardiovascular outcomes in patients with diabetes |
Q51064693 | Vitamin D suppresses oxidative stress-induced microparticle release by human umbilical vein endothelial cells |
Search more.